NRx Pharmaceuticals, Inc. today announced that management will report second quarter 2022 financial results prior to the market open on August 15, 2022.
Q2 Earnings
Aug. 10, 2022
NRx Pharmaceuticals to Report Second Quarter 2022 Results on August 15, 2022
Aug. 16, 2021
NRx Pharmaceuticals Announces 2nd Quarter 2021 Financial Update
Emergency Use Authorization (EUA) Request for ZYESAMI™ (aviptadil) Pending with United States Food and Drug Administration to Treat Patients Suffering from Critical COVID-19 with Respiratory Failure Emergency Use Authorization Granted to ZYESAMI in Nation of Georgia to Treat Critical COVID-19 Patients in July; First Orders for ZYESAMI in Georgia Under Discussion NRx Pharmaceuticals Initiating Phase […]